|
46
|
203
|
7dpqA |
Hiv-1 protease d30n mutant |
|
45
|
203
|
7dozA |
Hiv-1 protease d30n mutant in complex with nelfinavir |
|
17
|
99
|
7n6tA |
Crystal structure of inhibitor-free hiv-1 prs17 revertant mutant prs17 v48g |
|
19
|
99
|
7n6xA |
Crystal structure of hiv-1 protease multiple mutants prs17 bound to inhibitor amprenavir |
|
18
|
99
|
7n6vA |
Crystal structure of hiv-1 protease multiple mutants prs17 with revertant mutation v48g bound to inhibitor amprenavir |
|
19
|
99
|
7myyA |
Crystal structure of hiv-1 prs17 with grl-142 |
|
104
|
423
|
7dbmB |
Hiv-1 reverse transcriptase mutant q151m/y115f/f116y/m184v:dna:dgtp ternary complex |
|
163
|
552
|
7dbmA |
Hiv-1 reverse transcriptase mutant q151m/y115f/f116y/m184v:dna:dgtp ternary complex |
|
20
|
99
|
7mypA |
Crystal structure of hiv-1 prs17 with grl-44-10a |
|
18
|
99
|
6w6tA |
Wt hiv-1 protease in complex with phosphonated umass6 (pu6) |
|
18
|
99
|
6uwcA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08613 |
|
20
|
99
|
6uwbA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-08513 |
|
18
|
99
|
6vodA |
Hiv-1 wild type protease with grl-052-16a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand |
|
19
|
99
|
6voeA |
Hiv-1 wild type protease with grl-019-17a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand and a aminobenzothiazole(abt)-based p2'-ligand |
|
19
|
99
|
6vceA |
Hiv-1 wild type protease with grl-026-18a, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a p2 ligand |
|
20
|
99
|
6oydA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-004 |
|
20
|
99
|
6oyrA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-002 |
|
19
|
99
|
6ogrA |
X-ray crystal structure of darunavir-resistant hiv-1 protease (p30) in complex with grl-142 |
|
19
|
99
|
6ogqA |
X-ray crystal structure of darunavir-resistant hiv-1 protease (p30) in complex with grl-003 |
|
19
|
99
|
6oglA |
X-ray crystal structure of darunavir-resistant hiv-1 protease (p51) in complex with grl-003 |
|
20
|
99
|
6ogsA |
X-ray crystal structure of darunavir-resistant hiv-1 protease (p30) in complex with grl-001 |
|
20
|
99
|
6ogpA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-063 |
|
17
|
99
|
6ogvA |
X-ray crystal structure of darunavir-resistant hiv-1 protease (p30) in apo state |
|
19
|
99
|
6ogtA |
X-ray crystal structure of darunavir-resistant hiv-1 protease (p51) in complex with grl-001 |
|
18
|
99
|
6i45A |
Crystal structure of i13v/i62v/v77i south african hiv-1 subtype c protease containing a d25a mutation |
|
17
|
99
|
6prfA |
Hiv-1 protease multiple drug resistant clinical isolate mutant pr20 with grl-14213a |
|
19
|
99
|
6mk9A |
X-ray crystal structure of darunavir-resistant-p51 hiv-1 protease in complex with grl-121 |
|
20
|
99
|
6mklA |
X-ray crystal structure of darunavir-resistant-p51 hiv-1 protease in complex with grl-142 |
|
19
|
99
|
6u7pA |
Hiv-1 wild type protease with grl-03119a, with phenyl-boronic-acid as p2'-ligand and with a hexahydro-4h-furo-pyran as the p2-ligand |
|
19
|
99
|
6u7oA |
Hiv-1 wild type protease with grl-00819a, with phenyl-boronic-acid as p2'-ligand and with a 6-5-5-ring fused crown-like tetrahydropyranofuran as the p2-ligand |
|
0
|
5
|
2je4C |
Atomic-resolution crystal structure of chemically-synthesized hiv-1 protease in complex with jg-365 |
|
0
|
5
|
3b80C |
Hiv-1 protease mutant i54v complexed with gem-diol-amine intermediate nlltqi |
|
0
|
4
|
4f74C |
Crystal structure of active hiv-1 protease in complex with the n terminal product of the substrate ma-ca. |
|
18
|
99
|
6c8xA |
Wild-type hiv-1 protease in complex with a phenylboronic acid (p2') analog of darunavir |
|
18
|
99
|
6dv4A |
Hiv-1 wild type protease with grl-04315a, a tetrahydronaphthalene carboxamide with (r)-boc-amine and (s)-hydroxyl functionalities as the p2 ligand |
|
17
|
99
|
6dv0A |
Hiv-1 wild type protease with grl-02815a, a thiochroman heterocycle with (s)-boc-amine functionality as the p2 ligand |
|
19
|
99
|
6c8yA |
D30n hiv-1 protease in complex with a phenylboronic acid (p2') analog of darunavir |
|
19
|
99
|
6e9aA |
Hiv-1 wild type protease with grl-034-17a, (3as, 5r, 6ar)-2-oxohexahyd cyclopenta[d]-5-oxazolyl urethane with a bicyclic oxazolidinone scaff as the p2 ligand |
|
19
|
99
|
6e7jA |
Hiv-1 wild type protease with grl-042-17a, 3-phenylhexahydro-2h-cyclopenta[d]oxazol-2-one with a bicyclic oxazolidinone scaffold as the p2 ligand |
|
18
|
99
|
6dh2A |
Crystal structure of hiv-1 protease nl4-3 i84v mutant in complex with umass6 |
|
17
|
99
|
6dh8A |
Crystal structure of hiv-1 protease nl4-3 i50v mutant in complex with umass6 |
|
19
|
99
|
6dh7A |
Crystal structure of hiv-1 protease nl4-3 i50v mutant in complex with umass1 |
|
17
|
99
|
6dh5A |
Crystal structure of hiv-1 protease nl4-3 v82i mutant in complex with umass6 |
|
18
|
99
|
6dh6A |
Crystal structure of hiv-1 protease nl4-3 i50v mutant in complex with darunavir |
|
18
|
99
|
6dgyA |
Crystal structure of hiv-1 protease nl4-3 wt in complex with umass1 |
|
19
|
99
|
6dgxA |
Crystal structure of hiv-1 protease nl4-3 wt in complex with darunavir |
|
19
|
99
|
6dh4A |
Crystal structure of hiv-1 protease nl4-3 v82i mutant in complex with umass1 |
|
17
|
99
|
6dh1A |
Crystal structure of hiv-1 protease nl4-3 i84v mutant in complex with umass1 |
|
18
|
99
|
6dh0A |
Crystal structure of hiv-1 protease nl4-3 i84v mutant in complex with darunavir |
|
18
|
99
|
6dh3A |
Crystal structure of hiv-1 protease nl4-3 v82i mutant in complex with darunavir |
